{
    "clinical_study": {
        "@rank": "18223", 
        "arm_group": [
            {
                "arm_group_label": "group OI-A", 
                "arm_group_type": "Other", 
                "description": "Patients with irregular cycles undergoing FET in reproductive medicine renter of Sun Yat-sen Memorial Hospital will be recruited  , who should not be elder than 40 and had more than 3 frozen embryos.They will be randomized to receive the Letrozole and human chorionic gonadotrophin ovulation induced cycles."
            }, 
            {
                "arm_group_label": "group HRT-B", 
                "arm_group_type": "Other", 
                "description": "Patients with  irregular cycles undergoing FET in reproductive medicine renter of Sun Yat-sen Memorial Hospital will be recruited, who should not be elder than 40 and had more than 3 frozen embryos will be randomized to receive the estradiol and progesterone replacement therapy cycles."
            }
        ], 
        "brief_summary": {
            "textblock": "There are two main cycle regimens used for endometrial preparation for frozen embryo\n      transfer \uff08FET) in women with  irregular cycles: hormone replacement therapy cycles (HRT) in\n      which the endometrium is artificially prepared by estrogen and progesterone hormones\n      with/without a gonadotrophin releasing hormone agonist (GnRH-a) down regulation, and\n      ovulation induced cycles (OI) in which follicular development is supported with increasing\n      doses of gonadotrophin hormones and ovulation is induced. At present, there is still no\n      sufficient evidence that which kind of frozen embryo transfer cycle regimen to plan more\n      advantage. The purpose of this study was to compare the pregnancy outcome of hormone\n      replacement therapy cycles (HRT) and ovulation induced cycles (OI) in women with  irregular\n      cycles."
        }, 
        "brief_title": "The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "This study is a prospective randomized controlled trial. Patients with  irregular cycles\n      undergoing FET in reproductive medicine renter of Sun Yat-sen Memorial Hospital will be\n      recruited who should not be elder than 40 and had more than 3 frozen embryos. They will be\n      randomized to receive either the OI-FET cycle (group OI-A) or the HRT-FET cycle (group\n      HRT-B). In group OI-A, the follicular development is supported by Letrozole(LE) 2.5mg,once\n      daily,is introduced on cycle day 3 .And on cycle day 10 , a Vagina ultrasound is introduced\n      to monitor the development of the follicular ,following by intramuscular gonadotrophin\n      37.5~75 IU/d until there is a Luteinizing Hormone(LH) surge or ovulation .On the day\n      appearing Luteinizing Hormone surge\uff0cpatient is always introduced intramuscular human\n      chorionic gonadotrophin(HCG) 10000 IU.If there is sill no Luteinizing Hormone surge when the\n      follicle is 20-24mm ,the ovulation will be induced by HCG.Then the luteum is supported by\n      HCG  2000-2500 IU/3d.Transfer of thawed embryos will be performed 3 days after ovulation is\n      observed. In group HRT-B, oral estradiol, 2 mg, once daily, is introduced on cycle day 3\n      with an increasing doses protocol. If the endometrial thickness is greater than 7mm,\n      progesterone 40-60 mg in oil will be administered via intramuscular injection. Transfer of\n      thawed embryos will be performed 3 days later."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age forty years old or less\n\n          -  Has  irregular Menstruation (cycle more than 35 days or less than 24 days ) or has\n             regulation Menstruation but previous data suggest that abnormal ovulation\n\n          -  Frozen embryos number more than three\n\n        Exclusion Criteria:\n\n          -  Has Chocolate cyst or adenomyosis of uterus\n\n          -  Clear hydrosalpinx\n\n          -  Uterine scar or intrauterine adhesion and endometrial thickness \uff1c7mm before ovulation\n\n          -  recur thick endometrium\uff08\uff1c7mm\uff09\n\n          -  repeated implantation failure\uff08\u22653 times\uff09\n\n          -  Cancel the cycle because of having no dominant follicle in the ovulation\n             induction\uff08OI)+FET before or the growth of endometrium not good in the HRT+FET before"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "670", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01780610", 
            "org_study_id": "SunYatsenU2H- QZhang"
        }, 
        "intervention": [
            {
                "arm_group_label": "group OI-A", 
                "description": "the follicular development is supported by Letrozole(LE) 2.5mg,once daily is introduced on cycle day 3 .And on cycle day 10 , a Vagina ultrasound is introduced to monitor the development of the follicular ,following by intramuscular gonadotrophin 37.5~75 IU/d until there is a Luteinizing Hormone(LH) surge or ovulation .On the day appearing Luteinizing Hormone surge\uff0cpatients is always introduced intramuscular human chorionic gonadotrophin(HCG) 10000 IU.If there is sill no Luteinizing Hormone surge when the follicle is 20-24mm ,the ovulation will be induced by HCG.Then the luteum was supported by HCG 2000-2500 IU/3d.Transfer of thawed embryos will be performed 3 days after ovulation is observed.", 
                "intervention_name": "Letrozole and human chorionic gonadotrophin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Letrozole tablets", 
                    "HCG", 
                    "Chorionic gonadotrophin", 
                    "Chorionic gonadotropic hormone"
                ]
            }, 
            {
                "arm_group_label": "group HRT-B", 
                "description": "oral estradiol, 2 mg, once daily, was introduced on cycle day 3 with an increasing doses protocol. If the endometrial thickness was greater than 7mm, progesterone 40-60 mg in oil was administered via intramuscular injection. Transfer of thawed embryos was performed 3 days later", 
                "intervention_name": "estradiol and progesterone", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Estradiol Valerate", 
                    "Progynova", 
                    "3,20-pregnene-4; 4-pregnene-3,20-dione", 
                    "corpus luteum hormone", 
                    "luteal hormone"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chorionic Gonadotropin", 
                "Estradiol valerate", 
                "Estradiol 3-benzoate", 
                "Estradiol 17 beta-cypionate", 
                "Progesterone", 
                "Estradiol", 
                "Polyestradiol phosphate", 
                "Hormones", 
                "Letrozole"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "endometrium preparation protocols", 
            "frozen-thawed embryo transfer", 
            "irregular cycle", 
            "randomized controlled trial"
        ], 
        "lastchanged_date": "March 31, 2013", 
        "location": {
            "contact": {
                "last_name": "Zhang qingxue, doctor", 
                "phone": "13602797433"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510000"
                }, 
                "name": "Sun Yat-Sen Memorial Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles", 
        "overall_contact": {
            "last_name": "Zhang qixue, professor", 
            "phone": "13602737433"
        }, 
        "overall_official": {
            "affiliation": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
            "last_name": "Zhang qingxue, doctor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "12 weeks after pregnancy,people go Vaginal B ultrasonic examination\uff0cbeing saw gestational sac and heart tube beat as ongoing pregnancy", 
            "measure": "ongoing pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "12 weeks after pregnancy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01780610"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
            "investigator_full_name": "Qingxue Zhang", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "2 weeks after Embryo transplantation, people go urine HCG and blood HCG test\uff0cpositive as pregnancy", 
                "measure": "pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "2 weeks after Embryo transplantation"
            }, 
            {
                "description": "5 weeks after Embryo transplantation,people go Vaginal B ultrasonic\uff0cbeing saw the gestation sac as clinical pregnancy", 
                "measure": "clinical pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "5 weeks after Embryo transplantation"
            }
        ], 
        "source": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}